Institutional investors purchased a net $810.2 thousand shares of NEO during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 57.41% of shares outstanding that institutional investors hold is actually below the Medical/Nursing Services industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RMB CAPITAL MANAGEMENT LLC Bought 312.6 Thousand shares of Neogenomics Inc
ARTISAN PARTNERS LP Sold 12.0 Thousand shares of Neogenomics Inc